ApoE genotype accounts for the vast majority of AD risk and AD pathology
Top Cited Papers
- 30 June 2004
- journal article
- review article
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 25 (5), 641-650
- https://doi.org/10.1016/j.neurobiolaging.2003.12.023
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- Neuroplasticity in Alzheimer's diseaseJournal of Neuroscience Research, 2002
- The Reliability Theory of Aging and LongevityJournal of Theoretical Biology, 2001
- Expression of Human Apolipoprotein E4 in Neurons Causes Hyperphosphorylation of Protein Tau in the Brains of Transgenic MiceThe American Journal of Pathology, 2000
- High Frequency of Apolipoprotein E ϵ4 Allele in Young Individuals with Very Mild Alzheimer's Disease-Related Neurofibrillary ChangesExperimental Neurology, 1998
- Lack of apolipoprotein E dramatically reduces amyloid β-peptide depositionNature Genetics, 1997
- Do intersections of mortality-rate and survival functions have significance?Experimental Gerontology, 1995
- Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.JCI Insight, 1994
- Can an improved environment cause maximum lifespan to decrease? Comments on lifespan criteria and longitudinal Gompertzian analysisExperimental Gerontology, 1994
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993